4
MARKET OVERVIEW
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN ORTHOPEDIC BIOMATERIALS MARKET
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022–2024)
5.5.2
AVERAGE SELLING PRICE TREND, BY COUNTRY (2024)
5.6.1
IMPORT SCENARIO (HS CODE 7221)
5.6.2
EXPORT SCENARIO (HS CODE 7221)
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – ORTHOPEDIC BIOMATERIALS MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.11.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
PRECISION TECHNOLOGY
6.2
ADJACENT TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON ORTHOPEDIC BIOMATERIALS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
CASE STUDIES OF AI IMPLEMENTATION IN ORTHOPEDIC BIOMATERIALS MARKET
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ORTHOPEDIC BIOMATERIALS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, & ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ORTHOPEDIC BIOMATERIALS MARKET, BY TYPE, 2023–2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.2
METALLIC BIOMATERIALS
9.2.2
TITANIUM & TITANIUM ALLOYS
9.2.3
COBALT-CHROME ALLOYS
9.2.7
OTHER METALLIC BIOMATERIALS
9.3
POLYMERIC BIOMATERIALS
9.3.1
POLYMETHYLMETHACRYLATE (PMMA)
9.3.5
POLYETHERETHERKETONE (PEEK)
9.3.6
OTHER POLYMERIC BIOMATERIALS
9.5.9
OTHER NATURAL BIOMATERIALS
10
ORTHOPEDIC BIOMATERIALS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
APPLICATION-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS OF ORTHOPEDIC BIOMATERIALS IN DIVERSE INDUSTRIES
10.2.3
SHOULDER REPLACEMENTS
10.2.4
OTHER JOINT REPLACEMENT APPLICATIONS
10.3.2
MINIMALLY INVASIVE FUSION
10.3.3
MOTION PRESERVATION & DYNAMIC STABILIZATION
10.3.3.1
PEDICLE-BASED ROD SYSTEMS
10.3.3.2
INTERSPINOUS SPACERS
10.3.3.3
ARTIFICIAL DISCS
10.4
BIORESORBABLE TISSUE FIXATION
10.4.2
INTERFERENCE SCREWS
10.4.3
MENISCAL REPAIR TACKS
11
ORTHOPEDIC BIOMATERIALS MARKET, BY REGION, 2023–2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
11.2.3
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.3.7
MACROECONOMIC OUTLOOK FOR EUROPE
11.4.6
REST OF ASIA PACIFIC
11.4.7
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.5.4
REST OF LATIN AMERICA
11.5.5
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.6.1.2
UNITED ARAB EMIRATES
11.6.1.3
REST OF GCC COUNTRIES
11.6.2
REST OF MIDDLE EAST
11.6.3
MACROECONOMIC OUTLOOK FOR MIDDLE EAST
11.7.1
MACROECONOMIC OUTLOOK FOR AFRICA
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
12.2
KEY PLAYERS STRATEGIES/ RIGHT TO WIN
12.3
REVENUE ANALYSIS, 2022–2024
12.4
MARKET SHARE ANALYSIS,
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGION FOOTPRINT
12.5.5.3
PRODUCT FOOTPRINT
12.5.5.4
STERILITY TYPE FOOTPRINT
12.5.5.5
APPLICATION FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
12.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
12.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.7
COMPETITIVE SCENARIO
12.7.3
OTHER DEVELOPMENTS
12.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
12.9
VALUATION AND FINANCIAL METRICS
13.1.1
CELANESE CORPORATION
13.1.2
CARPENTER TECHNOLOGY CORPORATION
13.1.3
EVONIK INDUSTRIES AG
13.1.7
BERKELEY ADVANCED MATERIALS
13.1.8
CAM BIOCERAMICS B.V.
14.1.1.1
KEY SOURCES OF SECONDARY DATA
14.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
14.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
14.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
14.2
MARKET SIZE ESTIMATION
14.2.1
ORTHOPEDIC BIOMATERIALS MARKET SIZE ESTIMATION
14.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
14.2.1.2
MNM REPOSITORY ANALYSIS
14.2.1.3
SECONDARY ANALYSIS
14.2.1.4
PRIMARY RESEARCH
14.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
14.3
MARKET GROWTH RATE PROJECTIONS
14.6
RESEARCH ASSUMPTIONS
14.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in Orthopedic Biomaterials Market